Active substances

Onasemnogen abeparvovec›

M09AX09 Musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system

Indicated for: spinal muscular atrophy

Ondansetron›

A04AA01 Alimentary tract and metabolism | Antiemetics and antinauseants | Antiemetics and antinauseants | Serotonin (5ht3) antagonists

Indicated for: nausea and vomiting

Onion extract + heparin + allantoin›

C05BA53 Cardiovascular system | Antivaricose therapy | Heparins or heparinoids for topical use

Indicated for: hypertrophic scars; scar contractures

Opicapone›

N04BX04 Nervous system | Dopaminergic agents | Other dopaminergic agents

Indicated for: Parkinson's disease

Opium›

A07DA02 Alimentary tract and metabolism | Antipropulsives

Indicated for: diarrhea; pain

Oral cholera vaccine›

J07AE01 Antiinfectives for systemic use | Bacterial vaccines | Cholera vaccines

Indicated for: prevention of cholera

Oral polio vaccine + live attenuated trivalent vaccine›

J07BF02 Antiinfectives for systemic use | Viral vaccines | Poliomyelitis vaccines

Indicated for: prevention of poliomyelitis

Orlistat›

A08AB01 Alimentary tract and metabolism | Antiobesity preparations, excl. diet products | Peripherally acting antiobesity products

Indicated for: obesity; weight management

Ornidazole›

J01XD03 Antiinfectives for systemic use | Other antibacterials | Imidazole derivatives

Indicated for: bacterial and protozoal infections

Ornithine + aspartate›

A05BAN4 Alimentary tract and metabolism | Liver therapy, lipotropics

Indicated for: hepatic encephalopathy; hyperammonemia

Oseltamivir›

J05AH02 Antiinfectives for systemic use | Direct acting antivirals | Neuraminidase inhibitors

Indicated for: influenza

Osilodrostat›

H02CA02 Systemic hormonal preparations, excluding sex hormones and insulins | Antiadrenal preparations | Anticorticosteroids

Indicated for: endogenous Cushing syndrome

Osimertinib›

L01EB04 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Indicated for: non-small cell lung cancer

Ossein-hydroxyapatite complex›

M09AXN2 Musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system

Indicated for: osteoporosis; bone mineral deficiency

Otilonium bromide›

A03AB06 Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Drugs for functional gastrointestinal disorders | Synthetic anticholinergics, quaternary ammonium compounds

Indicated for: gastrointestinal spasms; functional abdominal pain

Oxaceprol›

M01AX24 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Other antiinflammatory and antirheumatic agents, non-steroids

Indicated for: osteoarthritis; degenerative joint disorders

Oxacillin›

J01CF04 Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Beta-lactamase resistant penicillins

Indicated for: bacterial infections

Oxaliplatin›

L01XA03 Antineoplastic and immunomodulating agents | Other antineoplastic agents | Platinum compounds

Indicated for: colorectal cancer

Oxaprozin›

M01AE12 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Propionic acid derivatives

Indicated for: pain and inflammation

Oxcarbazepine›

N03AF02 Nervous system | Antiepileptics | Antiepileptics | Carboxamide derivatives

Indicated for: epilepsy

Oxeladine›

R05DB09 Respiratory system | Cough suppressants, excl. combinations with expectorants | Other cough suppressants

Indicated for: dry cough

Oxybuprocaine hydrochloride›

S01HA02 Sensory organs | Local anesthetics

Indicated for: local anesthesia

Oxybutynin›

G04BD04 Genito urinary system and sex hormones | Urologicals | Urologicals | Drugs for urinary frequency and incontinence

Indicated for: overactive bladder; urinary incontinence

Oxycodone›

N02AA05 Nervous system | Opioids | Natural opium alkaloids

Indicated for: moderate to severe pain

Oxycodone + naloxone›

N02AA55 Nervous system | Opioids | Natural opium alkaloids

Indicated for: moderate to severe pain

Oxygen›

V03AN01 Various | All other therapeutic products | All other therapeutic products | Medical gases

Indicated for: oxygen therapy

Oxymetazoline›

R01AA05 Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, plain

Indicated for: nasal congestion; rhinitis

Oxytetracycline + dexamethasone›

S01CA01 Sensory organs | Antiinflammatory agents and antiinfectives in combination | Corticosteroids and antiinfectives in combination

Indicated for: ophthalmic antibacterial and anti-inflammatory treatment after eye surgery or for bacterial eye infections with inflamma

Oxytetracycline + hydrocortisone›

D07CA01 Dermatologicals | Corticosteroids, combinations with antibiotics | Corticosteroids, weak, combinations with antibiotics

Indicated for: bacterial infections

Oxytocin›

H01BB02 Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Oxytocin and analogues

Indicated for: uterine contractions; postpartum hemorrhage